GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA)

Symbol: TARA on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$4,356,728	817,196	+58,477	+7.7%	$5.33	Q4 2025
30 Sep 2025	0%	+0%	$3,301,348	758,719	+14,200	+1.9%	$4.35	Q3 2025
30 Jun 2025	0%	+0%	$2,256,485	744,519	+397,822	+115%	$3.03	Q2 2025
31 Mar 2025	0%	+0%	$1,477,940	346,697	+167,104		$4.26	Q1 2025
31 Dec 2024	0%	+0%	$948,351	179,593	+9,553	+5.6%	$5.28	Q4 2024
30 Sep 2024	0%	+0%	$311,201	170,040	+29,514	+21%	$1.83	Q3 2024
30 Jun 2024	0%	+0%	$292,327	140,526	+57,619	+69%	$2.08	Q2 2024
31 Mar 2024	0%	+0%	$332,519	82,907	+4,389	+5.6%	$4.01	Q1 2024
31 Dec 2023	0%	0%	$146,855	78,518	0		$1.87	Q4 2023
30 Sep 2023	0%	-0%	$131,151	78,518	-4,902	-5.9%	$1.67	Q3 2023
30 Jun 2023	0%	0%	$199,373	83,420	0		$2.39	Q2 2023
31 Mar 2023	0%	0%	$258,602	83,420	0		$3.10	Q1 2023
31 Dec 2022	0%	0%	$223,000	83,420	-224	-0.27%	$2.67	Q4 2022
30 Sep 2022	0%	0%	$247,000	83,644	0		$2.95	Q3 2022
30 Jun 2022	0%	+0%	$245,000	83,644	+1,680	+2%	$2.93	Q2 2022
31 Mar 2022	0%	+0%	$418,000	81,964	+2,947	+3.7%	$5.10	Q1 2022
31 Dec 2021	0%	0%	$533,000	79,017	0		$6.75	Q4 2021
30 Sep 2021	0%	-0%	$546,000	79,017	-3,968	-4.8%	$6.91	Q3 2021
30 Jun 2021	0%	-0%	$808,000	82,985	-28,077	-25%	$9.74	Q2 2021
31 Mar 2021	0%	+0%	$1,748,000	111,062	+6,182	+5.9%	$15.74	Q1 2021
31 Dec 2020	0%	+0%	$2,539,000	104,880	+84,598	+417%	$24.21	Q4 2020
30 Sep 2020	0%	+0%	$341,000	20,282	+2,838	+16%	$16.81	Q3 2020
30 Jun 2020	0%	+0%	$511,000	17,444	+17,444	NEW	$29.29	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.